Claude
What's Next
Verdict at ₹335
Current Price (₹)
Prob-Weighted Value (₹)
Position Size
Catalyst Calendar: Next 6 Months
What the market will watch most closely: Q4 FY26 results (expected May 2026). If the company posts another operating loss in Q4 – typically a decent quarter – it confirms FY26 as a total washout with no seasonal recovery. The stock at ₹335 already prices in significant distress (0.92x book), but book value itself is eroding at roughly ₹20-25 per share annually if current losses persist.
There is no real near-term catalyst. The new CEO has articulated no public strategic plan. The VP-Roofing resigned in February 2026, making this the third senior departure in 12 months (CEO, CFO, now VP-Roofing). The building products industry remains in overcapacity. PEB order book visibility has not been disclosed. Rural demand indicators remain weak. Without a specific event that can plausibly bend the margin curve, waiting costs nothing.
LEAPS / Options
No options data available for EVERESTIND. Indian small-cap stocks on NSE/BSE generally lack liquid listed options. There is no actionable options setup for this name. The equity verdict stands on its own: SELL / AVOID.